electroCore Stock
electroCore, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Joshua Lev
- Employees
- 83
- Market cap
- $71 M
- IPO
- 22/06/2018
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat…
electroCore stock: price history
1D
-6.0%
1W
-18.7%
1M
-26.3%
6M
+20.8%
YTD
+74.8%
1Y
+56.4%
2Y
-1.9%
5Y
-47.5%
10Y
–
Next earnings date
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~13% stronger price swings than usual
Ask the agents about electroCore
Analyst assessment of electroCore
0
STRONG BUY
3
BUY
3
HOLD
0
SELL
0
STRONG SELL
6
TOTAL · Buy
As of: 26/01/2026
electroCore stock metrics
P/E
-4.62
P/B
-26.46
EV/EBITDA
-5.76
RETURN ON EQUITY
109.6%
NET MARGIN
-32.4%
DEBT/EQUITY
-3.43
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
66.3%
FLOAT SHARES
5,981,048
AVG. DAILY VOLUME (30D)
83,710
Insider transactions (SEC)
Errico Thomas J.
Fox Michael
Lev Joshua S.
GANDOLFO JOHN P
Errico Thomas J.
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about electroCore stock
What does electroCore do?
electroCore, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Joshua Lev, the company employs around 83 people.
The IPO was on 22/06/2018; the stock trades on NASDAQ under the ticker ECOR.
What do analysts say about electroCore stock?
6 analysts rate the stock, the consensus is Buy (as of 26/01/2026).
This is an external assessment, not a statement by Market Jury.
When does electroCore report next?
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 13% stronger than usual.
Does electroCore pay a dividend?
No, electroCore currently does not pay a dividend.
Which stocks are comparable to electroCore?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get electroCore stock analyzed?
Clicking "Analyze stock" lets five strategies assess electroCore against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.